4.7 Article

Circulating microRNA Biomarker for Detecting Breast Cancer in High-Risk Benign Breast Tumors

Journal

Publisher

MDPI
DOI: 10.3390/ijms24087553

Keywords

breast cancer; benign breast tumor; high-risk benign breast lesion; plasma; miRNA biomarker; proteomics; IGF-1

Ask authors/readers for more resources

This study aimed to identify circulating miRNAs that can serve as detection markers for breast cancer arising from high-risk benign tumors. Four miRNAs were found to differentiate early-stage breast cancer from high-risk benign tumors, and were associated with the IGF-1 pathway. These miRNAs have the potential to be biomarkers for detecting early-stage breast cancer.
High-risk benign breast tumors are known to develop breast cancer at high rates. However, it is still controversial whether they should be removed during diagnosis or followed up until cancer development becomes evident. Therefore, this study sought to identify circulating microRNAs (miRNAs) that could serve as detection markers of cancers arising from high-risk benign tumors. Small RNA-seq was performed using plasma samples collected from patients with early-stage breast cancer (CA) and high-risk (HB), moderate-risk (MB), and no-risk (Be) benign breast tumors. Proteomic profiling of CA and HB plasma was performed to investigate the underlying functions of the identified miRNAs. Our findings revealed that four miRNAs, hsa-mir-128-3p, hsa-mir-421, hsa-mir-130b-5p, and hsa-mir-28-5p, were differentially expressed in CA vs. HB and had diagnostic power to discriminate CA from HB with AUC scores greater than 0.7. Enriched pathways based on the target genes of these miRNAs indicated their association with IGF-1. Furthermore, the Ingenuity Pathway Analysis performed on the proteomic data revealed that the IGF-1 signaling pathway was significantly enriched in CA vs. HB. In conclusion, these findings suggest that these miRNAs could potentially serve as biomarkers for detecting early-stage breast cancer from high-risk benign tumors by monitoring IGF signaling-induced malignant transformation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available